Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats

European Neuropsychopharmacology

Volumn 25, Issue 11, 2015, Pages 2157-2169

  Carnevali, Luca ^a   Vacondio, Federica ^a   Rossi, Stefano ^a   Callegari, Sergio ^b   Macchi, Emilio ^a   Spadoni, Gilberto ^c   Bedini, Annalida ^c   Rivara, Silvia ^a   Mor, Marco ^a   Sgoifo, Andrea ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b Vaio Hospital   (Italy)

^c UNIVERSITY OF URBINO   (Italy)

Author keywords

Arrhythmia; Depression; Endocannabinoid system; Heart rate variability; Stress

Indexed keywords

ANANDAMIDE; ANTIDEPRESSANT AGENT; CARDIOVASCULAR AGENT; CORTICOSTERONE; FATTY ACID AMIDASE INHIBITOR; N OLEOYLETHANOLAMINE; PALMIDROL; SUCROSE; UNCLASSIFIED DRUG; URB 694; AMIDASE; BIPHENYL DERIVATIVE; CARBAMIC ACID DERIVATIVE; CARDIOTONIC AGENT; CYCLOHEXYL CARBONIC ACID 3'-CARBAMOYL-3-YL ESTER; FATTY-ACID AMIDE HYDROLASE; SUGAR INTAKE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDEPRESSANT ACTIVITY; ARTICLE; AUTONOMIC NERVOUS SYSTEM FUNCTION; BEHAVIOR CHANGE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DEPRESSION; DRUG SAFETY; ELECTRIC ACTIVITY; ELECTROCARDIOGRAM; FEMALE; FORCED SWIM TEST; HEART ARRHYTHMIA; HEART INNERVATION; HEART PROTECTION; HEART RATE VARIABILITY; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HYPERACTIVITY; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SOCIAL STRESS; SUCROSE PREFERENCE TEST; TELEMETRY; WEIGHT REDUCTION; WISTAR KYOTO RAT; ANHEDONIA; ANIMAL; ANTAGONISTS AND INHIBITORS; ARRHYTHMIAS, CARDIAC; BLOOD; BODY WEIGHT; DECISION MAKING; DEPRESSIVE DISORDER; DISEASE MODEL; DRUG EFFECTS; FOOD PREFERENCE; HEART RATE; MENTAL STRESS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SUGAR INTAKE;

AMIDOHYDROLASES; ANHEDONIA; ANIMALS; ANTIDEPRESSIVE AGENTS; ARRHYTHMIAS, CARDIAC; BIPHENYL COMPOUNDS; BODY WEIGHT; CARBAMATES; CARDIOTONIC AGENTS; CHOICE BEHAVIOR; CORTICOSTERONE; DEPRESSIVE DISORDER; DIETARY SUCROSE; DISEASE MODELS, ANIMAL; FOOD PREFERENCES; HEART RATE; MALE; RATS, INBRED WKY; STRESS, PSYCHOLOGICAL;

EID: 84947484653     PISSN: 0924977X     EISSN: 18737862     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2015.07.015     Document Type: Article

References (62)

1. Albus C. Psychological and social factors in coronary heart disease. Ann. Med. 2010, 42:487-494.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychatric Press, Washington, DC. fifth ed.
3. Báez-Mendoza R., Schultz W. The role of the striatum in social behavior. Front. Neurosci. 2013, 7:233.
4. Becker C., Zeau B., Rivat C., Blugeot A., Hamon M., Benoliel J.J. Repeated social defeat-induced depression-like behavioral and biological alterations in rats: involvement of cholecystokinin. Mol. Psychiatry 2008, 13:1079-1092.
5. Bisogno T., Berrendero F., Ambrosino G., Cebeira M., Ramos J.A., Fernandez-Ruiz J.J., Di Marzo V. Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function. Biochem. Biophys. Res. Commun. 1999, 256:377-380.
6. Bonz A., Laser M., Kullmer S., Kniesch S., Babin-Ebell J., Popp V., Ertl G., Wagner J.A. Cannabinoids acting on CB1 receptors decrease contractile performance in human atrial muscle. J. Cardiovasc. Pharmacol. 2003, 41:657-664.
7. Bortolato M., Mangieri R.A., Fu J., Kim J.H., Arguello O., Duranti A., Tontini A., Mor M., Tarzia G., Piomelli D. Antidepressant-like activity of the fatty acid amide hydrolase inhibitor URB597 in a rat model of chronic mild stress. Biol. Psychiatry 2007, 62:1103-1110.
8. Browne C.A., van Nest D.S., Lucki I. Antidepressant-like effects of buprenorphine in rats are strain dependent. Behav. Brain. Res. 2015, 278:385-392.
9. Calil C.M., Marcondes F.K. The comparison of immobility time in experimental rat swimming models. Life Sci. 2006, 79:1712-1719.
10. Carnevali L., Trombini M., Graiani G., Madeddu D., Quaini F., Landgraf R., Neumann I.D., Nalivaiko E., Sgoifo A. Low vagally-mediated heart rate variability and increased susceptibility to ventricular arrhythmias in rats bred for high anxiety. Physiol. Behav. 2014, 128:16-25.
11. Carnevali L., Trombini M., Rossi S., Graiani G., Manghi M., Koolhaas J.M., Quaini F., Macchi E., Nalivaiko E., Sgoifo A. Structural and electrical myocardial remodeling in a rodent model of depression. Psychosom. Med. 2013, 75:42-51.
12. Carney R.M., Freedland K.E., Veith R.C. Depression, the autonomic nervous system, and coronary heart disease. Psychosom. Med. 2005, 67(Suppl 1):S29-S33.
13. Carroll B.J., Cassidy F., Naftolowitz D., Tatham N.E., Wilson W.H., Iranmanesh A., Liu P.Y., Veldhuis J.D. Pathophysiology of hypercortisolism in depression. Acta Psychiatr. Scand. Suppl. 2007, 90-103.
14. Clapper J.R., Vacondio F., King A.R., Duranti A., Tontini A., Silva C., Sanchini S., Tarzia G., Mor M., Piomelli D. A second generation of carbamate-based fatty acid amide hydrolase inhibitors with improved activity in vivo. ChemMedChem 2009, 4:1505-1513.
15. Crowe M.S., Nass S.R., Gabella K.M., Kinsey S.G. The endocannabinoid system modulates stress, emotionality, and inflammation. Brain Behav. Immun. 2014, 42:1-5.
16. Cryan J.F., Page M.E., Lucki I. Differential behavioral effects of the antidepressants reboxetine, fluoxetine, and moclobemide in a modified forced swim test following chronic treatment. Psychopharmacology (Berl) 2005, 182:335-344.
17. Curtis M.J., Hancox J.C., Farkas A., Wainwright C.L., Stables C.L., Saint D.A., Clements-Jewery H., Lambiase P.D., Billman G.E., Janse M.J., Pugsley M.K., Ng G.A., Roden D.M., Camm A.J., Walker M.J. The Lambeth Conventions (II): guidelines for the study of animal and human ventricular and supraventricular arrhythmias. Pharmacol. Ther. 2013, 139:213-248.
18. Fiorelli C., Scarpelli R., Piomelli D., Bandiera T. Development of a multigram synthesis of URB937, a peripherally restricted FAAH inhibitor. Org. Process. Res. Dev. 2013, 17:359-367.
19. Gobbi G., Bambico F.R., Mangieri R., Bortolato M., Campolongo P., Solinas M., Cassano T., Morgese M.G., Debonnel G., Duranti A., Tontini A., Tarzia G., Mor M., Trezza V., Goldberg S.R., Cuomo V., Piomelli D. Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc. Natl. Acad. Sci. USA 2005, 102:18620-18625.
20. Gorzalka B.B., Hill M.N. Putative role of endocannabinoid signaling in the etiology of depression and actions of antidepressants. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35:1575-1585.
21. Grippo A.J., Carter C.S., McNeal N., Chandler D.L., Larocca M.A., Bates S.L., Porges S.W. 24-hour autonomic dysfunction and depressive behaviors in an animal model of social isolation: implications for the study of depression and cardiovascular disease. Psychosom. Med. 2011, 73:59-66.
22. Hiley C.R. Endocannabinoids and the heart. J. Cardiovasc. Pharmacol. 2009, 53:267-276.
23. Hill M.N., McLaughlin R.J., Pan B., Fitzgerald M.L., Roberts C.J., Lee T.T., Karatsoreos I.N., Mackie K., Viau V., Pickel V.M., McEwen B.S., Liu Q.S., Gorzalka B.B., Hillard C.J. Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response. J. Neurosci. 2011, 31:10506-10515.
24. Jordan J.L., Mendel W.J. Disorders of sinus function 1995, 245-295. Lippincott, Philadelphia. W.J.E. Mandel (Ed.).
25. Kemp A.H., Brunoni A.R., Santos I.S., Nunes M.A., Dantas E.M., Carvalho de Figueiredo R., Pereira A.C., Ribeiro A.L., Mill J.G., Andreao R.V., Thayer J.F., Bensenor I.M., Lotufo P.A. Effects of depression, anxiety, comorbidity, and antidepressants on resting-state heart rate and its variability: an ELSA-Brasil cohort baseline study. Am. J. Psychiatry 2014, 171:1328-1334.
26. Kemp A.H., Quintana D.S., Felmingham K.L., Matthews S., Jelinek H.F. Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: implications for cardiovascular risk. PLoS One 2012, 7:e30777.
27. Klengel T., Binder E.B. Gene-environment interactions in major depressive disorder. Can. J. Psychiatry 2013, 58:76-83.
28. Krylatov A.V., Ugdyzhekova D.S., Bernatskaya N.A., Maslov L.N., Mekhoulam R., Pertwee R.G., Stephano G.B. Activation of type II cannabinoid receptors improves myocardial tolerance to arrhythmogenic effects of coronary occlusion and reperfusion. Bull. Exp. Biol. Med. 2001, 131:523-525.
29. Lepicier P., Bouchard J.F., Lagneux C., Lamontagne D. Endocannabinoids protect the rat isolated heart against ischaemia. Br. J. Pharmacol. 2003, 139:805-815.
30. Liang C.S., Lee J.F., Chen C.C., Chang Y.C. Reactive heart rate variability in male patients with first-episode major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2014, 56C:52-57.
31. Licht C.M.M., de Geus E.J.C., van Dyck R., Penninx B.W.J.H Longitudinal evidence for unfavorable effects of antidepressants on heart rate variability. Biol. Psychiatry 2010, 68:861-868.
32. Lo Verme J., Fu J., Astarita G., La Rana G., Russo R., Calignano A., Piomelli D. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 2005, 67:15-19.
33. McKinney M.K., Cravatt B.F. Structure and function of fatty acid amide hydrolase. Annu. Rev. Biochem. 2005, 74:411-432.
34. Malkesman O., Lavi-Avnon Y., Maayan R., Weizman A. A cross-fostering study in a genetic animal model of depression: maternal behavior and depression-like symptoms. Pharmacol. Biochem. Behav. 2008, 91:1-8.
35. McLaughlin R.J., Hill M.N., Gorzalka B.B. A critical role for prefrontocortical endocannabinoid signaling in the regulation of stress and emotional behavior. Neurosci. Biobehav. Rev. 2014, 42:116-131.
36. Moldrich G., Wenger T. Localization of the CB1 cannabinoid receptor in the rat brain. an immunohistochemical study. Peptides 2000, 21:1735-1742.
37. Nam H., Clinton S.M., Jackson N.L., Kerman I.A. Learned helplessness and social avoidance in the Wistar-Kyoto rat. Front. Behav. Neurosci. 2014, 8:109.
38. Niederhoffer N., Szabo B Involvement of CB1 cannabinoid receptors in the EDHF-dependent vasorelaxation in rabbits. Br. J. Pharmacol. 1999, 126:1383-1386.
39. O'Mahony C.M., Clarke G., Gibney S., Dinan T.G., Cryan J.F. Strain differences in the neurochemical response to chronic restraint stress in the rat: relevance to depression. Pharmacol. Biochem. Behav. 2011, 97:690-699.
40. O'Malley D., Julio-Pieper M., Gibney S.M., Dinan T.G., Cryan J.F. Distinct alterations in colonic morphology and physiology in two rat models of enhanced stress-induced anxiety and depression-like behaviour. Stress 2010, 13:114-122.
41. Paxinos G., Watson C.R.R. The Rat Brain in Stereotaxic Coordinates 1986, Academic Press, Sydney, Australia.
42. Paré W.P., Redei E. Depressive behavior and stress ulcer in Wistar Kyoto rats. J. Physiol. Paris 1993, 87:229-238.
43. Plenis A., Konieczna L., Olędzka I., Kowalski P., Bączek T. Simultaneous determination of urinary cortisol, cortisone and corticosterone in parachutists, depressed patients and healthy controls in view of biomedical and pharmacokinetic studies. Mol. Biosyst. 2011, 7:1487-1500.
44. Porsolt R.D., Le Pichon M., Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977, 266:730-732.
45. Rademacher D.J., Meier S.E., Shi L., Ho W.S., Jarrahian A., Hillard C.J. Effects of acute and repeated restraint stress on endocannabinoid content in the amygdala, ventral striatum, and medial prefrontal cortex in mice. Neuropharmacology 2008, 54:108-116.
46. Ramaekers D., Beckers F., Demeulemeester H., Aubert A.E. Cardiovascular autonomic function in conscious rats: a novel approach to facilitate stationary conditions. Ann. Noninvasive Electrocardiol. 2002, 7:307-318.
47. Rea K., Olango W.M., Okine B.N., Madasu M.K., McGuire I.C., Coyle K., Harhen B., Roche M., Finn D.P. Impaired endocannabinoid signalling in the rostral ventromedial medulla underpins genotype-dependent hyper-responsivity to noxious stimuli. Pain 2014, 155:69-79.
48. Reich C.G., Taylor M.E., McCarthy M.M. Differential effects of chronic unpredictable stress on hippocampal CB1 receptors in male and female rats. Behav. Brain. Res. 2009, 203:264-269.
49. Reyes Del Paso G.A., Langewitz W., Mulder L.J., van Roon A., Duschek S. The utility of low frequency heart rate variability as an index of sympathetic cardiac tone: a review with emphasis on a reanalysis of previous studies. Psychophysiology 2013, 50:477-487.
50. Riebe C.J., Wotjak C.T. Endocannabinoids and stress. Stress 2011, 14:384-397.
51. Sgoifo A., Carnevali L., Grippo A.J. The socially stressed heart. Insights from studies in rodents. Neurosci. Biobehav. Rev. 2014, 39:51-60.
52. Sgoifo A., Koolhaas J.M., Musso E., De Boer S.F Different sympathovagal modulation of heart rate during social and nonsocial stress episodes in wild-type rats. Physiol. Behav. 1999, 67:733-738.
53. Surawicz B., Knilans T.K. Chou's Electrocardiography in Clinical Practice 2008, Elsevier S, Philadelphia.
54. Tarzia G., Duranti A., Gatti G., Piersanti G., Tontini A., Rivara S., Lodola A., Plazzi P.V., Mor M., Kathuria S., Piomelli D. Synthesis and structure-activity relationships of FAAH inhibitors: cyclohexylcarbamic acid biphenyl esters with chemical modulation at the proximal phenyl ring. ChemMedChem 2006, 1:130-139.
55. Udupa K., Sathyaprabha T.N., Thirthalli J., Kishore K.R., Lavekar G.S., Raju T.R., Gangadhar B.N. Alteration of cardiac autonomic functions in patients with major depression: a study using heart rate variability measures. J. Affect. Disord. 2007, 100:137-141.
56. Ugdyzhekova D.S., Bernatskaya N.A., Stefano J.B., Graier V.F., Tam S.W., Mekhoulam R. Endogenous cannabinoid anandamide increases heart resistance to arrhythmogenic effects of epinephrine: role of CB(1) and CB(2) receptors. Bull. Exp. Biol. Med. 2001, 131:251-253.
57. Underdown N.J., Hiley C.R., Ford W.R. Anandamide reduces infarct size in rat isolated hearts subjected to ischaemia-reperfusion by a novel cannabinoid mechanism. Br. J. Pharmacol. 2005, 146:809-816.
58. Vacondio F., Silva C., Lodola A., Carmi C., Rivara S., Duranti A., Tontini A., Sanchini S., Clapper J.R., Piomelli D., Tarzia G., Mor M. Biphenyl-3-yl alkylcarbamates as fatty acid amide hydrolase (FAAH) inhibitors: steric effects of N-alkyl chain on rat plasma and liver stability. Eur. J. Med. Chem. 2011, 46:4466-4473.
59. Van der Kooy K., van Hout H., Marwijk H., Marten H., Stehouwer C., Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int. J. Geriatr. Psychiatry 2007, 22:613-626.
60. Vertes R.P. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 2006, 142:1-20.
61. Vinod K.Y., Xie S., Psychoyos D., Hungund B.L., Cooper T.B., Tejani-Butt S.M. Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats. PLoS One 2012, 7:e36743.
62. Wood S.K., McFadden K.V., Grigoriadis D., Bhatnagar S., Valentino R.J. Depressive and cardiovascular disease comorbidity in a rat model of social stress: a putative role for corticotropin-releasing factor. Psychopharmacology (Berl) 2012, 222:325-336.